Beam Therapeutics Inc (BEAM)
24.38
+0.07
(+0.29%)
USD |
NASDAQ |
Apr 19, 12:02
Beam Therapeutics Shareholders Equity (Quarterly): 981.33M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 981.33M |
| September 30, 2023 | 778.94M |
| June 30, 2023 | 811.64M |
| March 31, 2023 | 761.51M |
| December 31, 2022 | 733.47M |
| September 30, 2022 | 714.48M |
| June 30, 2022 | 800.16M |
| March 31, 2022 | 829.07M |
| December 31, 2021 | 826.74M |
| September 30, 2021 | 853.81M |
| Date | Value |
|---|---|
| June 30, 2021 | 548.55M |
| March 31, 2021 | 422.43M |
| December 31, 2020 | 245.56M |
| September 30, 2020 | 200.07M |
| June 30, 2020 | 230.82M |
| March 31, 2020 | 261.39M |
| December 31, 2019 | 100.94M |
| September 30, 2019 | 126.72M |
| June 30, 2019 | 143.65M |
| December 31, 2018 | 134.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
100.94M
Minimum
Dec 2019
981.33M
Maximum
Dec 2023
545.86M
Average
714.48M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 10.77B |
| Moderna Inc | 13.85B |
| Pfizer Inc | 89.01B |
| Editas Medicine Inc | 349.10M |
| Intellia Therapeutics Inc | 1.050B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.460B |
| Total Liabilities (Quarterly) | 478.38M |
| Current Ratio | 5.891 |